Current Report Filing (8-k)
March 15 2019 - 6:19AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
March 14, 2019
DRUG
FREE SOLUTION, INC.
(formerly known as Living Breathing Project, Inc.)
(Exact
name of registrant as specified in its charter)
Nevada
|
|
333-175525
|
|
99-0365611
|
(State
or other jurisdiction
|
|
(Commission
|
|
(IRS
Employer
|
of
incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
531
Main Street
El Segundo, California 90245
(Address of principal executive offices, including zip code)
(888)
615-6122
(Registrant’s telephone number, including area code)
Copies
to:
Peter Hogan
Buchalter Law Firm
1000 Wilshire Boulevard, Suite 1500
Los Angeles, CA 90017-1730
Tel: 213-891-5076
Fax: 213-896-0400
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (
see
General Instruction A.2. below):
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))
|
ITEM
5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS
OF CERTAIN OFFICERS
1.
Appointment of Chief Executive Officer.
A.
On March 13, 2019, Genie O’Malley has been reappointed as Chief Executive Officer to oversee the auditing of financial statements
from May 31, 2013 until current financial filing period. Upon completion these filings, Company will install a new Chief Executive
Officer.
B.
The Company has retained outside financial consultants to assist in the completion of outstanding filing periods. Completion of
filings is in progress.
SIGNATURES
Pursuant
to the requirements of the Securities and Exchange Act of 1934, Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
DRUG
FREE SOLUTION, INC.
|
|
|
|
Date:
March 14, 2019
|
By:
|
/s/ Genie O’Malley
|
|
Name:
|
Genie O’Malley
|
|
Title:
|
Chief Executive Officer
|
Drug Free Solutions (PK) (USOTC:DSOL)
Historical Stock Chart
From Nov 2024 to Dec 2024
Drug Free Solutions (PK) (USOTC:DSOL)
Historical Stock Chart
From Dec 2023 to Dec 2024